Compared with SMBG, rtCGM could improve glycemic control as well as reduce its complications, length of hospital stay, and frequency of emergency room visits in individuals with T1D who are treated with insulin [1-4]. The gene discussed is INS; the disease is type 1 diabetes mellitus.